Active Ingredient Brentuximab Vedotin
Active Ingredient Details
What is Brentuximab Vedotin?
Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA.
What is the usage for Brentuximab Vedotin?
Brentuximab is used to treat certain types of cancers (Hodgkin's lymphoma, systemic anaplastic large cell lymphoma, peripheral T-cell lymphoma, primary cutaneous anaplastic large cell lymphoma, CD30-expressing mycosis fungoides). It works by slowing or stopping the growth of cancer cells.
How many products in the NDC database contain Brentuximab Vedotin?
The NDC database has 4 products with the active ingredient Brentuximab Vedotin. The following table lists all the products that have this active ingredient.
NDC Products with Brentuximab Vedotin
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 49187-0212 | Proprietary Name: | Brentuximab Vedotin | Liquid | Lonza Ag | ACTIVE | ||
| 51144-050 | Proprietary Name: Adcetris | Brentuximab Vedotin | Injection, Powder, Lyophilized, For Solution | Intravenous | Seagen Inc. | ACTIVE | |
| 69443-050 | Proprietary Name: | Brentuximab Vedotin | Powder, For Solution | Baxter Oncology Gmbh | ACTIVE | ||
| 78848-003 | Proprietary Name: | Brentuximab Vedotin | Injection | Fareva | ACTIVE |